For the nine months ended September 30, 2026, the Company reported revenue of $1.413 billion, up 3.1%, and net income of $73.6 million. On October 6, 2026, it used approximately $93.5 million to acquire NEXDINE Hospitality.
HCSG · Healthcare Services Group Inc
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Up next
Latest documents
Healthcare Services Group, Inc. reported third-quarter revenue of $479.6 million and net income of $24.9 million, acquired Nextine Hospitality, and expects fourth-quarter revenue of $535 to $545 million and 2027 low double-digit growth.
Healthcare Services Group, Inc. reported third-quarter revenue of $479.6 million, net income and diluted EPS of $24.9 million and $0.36, acquired NEXDINE Hospitality for $93.5 million, and raised its 2027 revenue growth outlook from mid single-digits to low double-digits.
On October 6, 2026, Healthcare Services Group agreed to acquire NexDine, LLC and Xendella, LLC for approximately $93.5 million, subject to customary adjustments and contingent consideration, using cash on hand.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Oct 21, 2026TL;DR. HCSG raised its 2027 growth outlook, expanded through NEXDINE, reported $479.6 million of Q3 revenue, maintained strong liquidity and returned capital through share repurchases. Risks include potentially higher bad debt, workers' compensation volatility, an unresolved Genesis recovery, an expected negative Q4 payroll-accrual impact on reported cash flow and inflation that may not be passed through to customers.
- + HCSG raised its 2027 revenue growth outlook from mid single-digits to low double-digits.
- + The NEXDINE acquisition is expected to contribute over $150 million in annual revenue at comparable margins and be immediately accretive to earnings.
- + Q3 revenue was $479.6 million.
- + Cost of services was 83.2%, benefiting from strong service execution and lower bad debt expense.
- + HCSG ended Q3 with $204.3 million of cash and marketable securities and an unutilized $300.0 million credit facility.
- + HCSG repurchased $56.6 million of common stock year to date under its February 2026 plan.
- − Payment delays or customer restructurings could result in significant additional bad debt.
- − An unpredictable spike in workers' compensation incidents and severity could reverse cost-of-services improvements.
- − The final Genesis recovery remains subject to unresolved variables and contingencies.
- − Payroll-accrual timing is expected to have an 18 million dollar negative impact on Q4 reported cash flow.
- − Continued inflation could adversely affect results if labor, materials, supplies and equipment cost increases cannot be passed on to customers.
- − The NEXDINE transaction is expected to create an earnings offset from lost interest income on close to $90 to $100 million of cash.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Still-open targets the latest release did not restate under the same label.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Costs of services provided as a percentage of revenues | 84.1% | three months ended June 30, 2026 filing | — |
| Dietary labor and labor-related costs as a percentage of segment revenue | 58.2% | three months ended June 30, 2026 filing | — |
| EVS labor and labor-related costs as a percentage of segment revenue | 76.6% | three months ended June 30, 2026 filing | — |
| Segment expenses for Dietary as a percentage of Dietary revenues | 92.5% | three months ended June 30, 2026 filing | — |
| Segment expenses for EVS as a percentage of EVS revenues | 86.7% | three months ended June 30, 2026 filing | — |
| Segment margin | 13.3% | Three Months Ended June 30, 2026 filing | — |
| Segment profit | $47.63M | Three Months Ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Care Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HCSG
this stock
Healthcare Services Group Inc
|
$1.69B | +31.3% | +7.1% | 17.0 | 3.7% |
|
HCA
HCA Healthcare, Inc.
|
$99.51B | +2.0% | +7.1% | 15.8 | 2.3% |
|
FSNUY
Fresenius SE & Co. KGaA
|
$33.07B | +2.4% | — | — | 0.0% |
|
THC
Tenet Healthcare Corp
|
$21.60B | +36.5% | +0.9% | 7.9 | 2.2% |
|
EHC
Encompass Health Corp
|
$13.24B | +27.1% | +10.5% | 21.1 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 23, 2026
- This year
- 13
For the nine months ended September 30, 2026, the Company reported revenue of $1.413 billion, up 3.1%, and net income of $73.6 million. On October 6, 2026, it used approximately $93.5 million to acquire NEXDINE Hospitality.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HCSG | -0.4% | +15.6% | +21.8% | +2.4% | +31.3% |
| SPY | -3.9% | -5.6% | -3.5% | -3.4% | +7.1% |
| vs SPY | +3.5% | +21.2% | +25.3% | +5.8% | +24.2% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.